These Delicious, Easy to Prep, Gluten-Free Meals will Make Your Gut Happy
Nashville, TN, August 11, 2020 ̶ ̶ Rancher, restauranteur and TV cooking personality Mee McCormick serves up delicious, gluten-free recipes designed for optimal gut health in her latest cookbook, My Pinewood Kitchen: A Southern Culinary Cure. With everything from immune-boosting smoothies to soups with probiotic power and reimagined Southern entrees, My Pinewood Kitchen is packed with microbiome-friendly meals that give new meaning to the phrase comfort food.
Every recipe in the book is gluten-free and created for optimal health benefits, even decadent sounding dishes like Kentucky Caramel Chicken and Veggie Mac and Cheese. There are more than 130 recipes, and each one can be customized for Keto, Paleo or vegan diets. It truly is an "all-inclusive" eating plan for everyone in the family.
McCormick first turned to the healing power of food when doctor after doctor offered very little relief for her Crohn’s disease, rheumatoid arthritis and Hashimoto's. Her switch to whole-food cooking helped her heal her gut and her immune system and completely altered the trajectory of her life.
My Pinewood Kitchen is a follow-up to her wildly successful, life-enhancing My Kitchen Cure. Mee is living proof that you can change your fate by what’s on your plate, and her recipes will help heal your gut and fight a host of autoimmune diseases.
Mee has since forged the way for a new kind of hospitality: a fully-inclusive table where everyone can eat delicious Southern comfort classics without sacrificing taste, regardless of even the most severe food allergies or dietary restrictions – all while stressing the importance of intestinal health and how to improve your own gut microbiome. Her book shows us which foods are nutritional powerhouses and which ones we must avoid, and how to eat real food every day without breaking the bank.
Mee McCormick is a rising Southern culinary and wellness innovator, restaurateur, author, TV cooking personality, farmer, rancher, wife and mother. She splits her time between Nashville and nearby Nunnelly, Tennessee; a tiny, unincorporated community in Hickman County; home to her biodynamic farm and restaurant Pinewood Kitchen & Mercantile – that is unique in that every meal is created with the intention to serve everyone with the same deliciousness, regardless of dietary restrictions. In fact, some members of the community drive hours to get a taste of her farm-to-table cuisine and her mouthwatering Pinewood’s Grain-Free Fried Chicken!
Mee authored her first cookbook My Kitchen Cure, which led to wild success and a book deal with HCI for her second cookbook, My Pinewood Kitchen, published in April 2020. She frequently appears on Today in Nashville, and she participates in nationally-recognized food festivals and events, spreading the same level of care and hospitality to audiences everywhere that she has become known for throughout the state of Tennessee. Visit: www.meemccormick.com or www.pinewoodkitchenandmercantile.com.
My Pinewood Kitchen: A Southern Culinary Cure/130+ Crazy Delicious, Gluten-Free Recipes to Reduce Inflammation and Make Your Gut Happy
By Mee McCormick
HCI BOOKS / $26.95
ISBN: 9780757323522
Available wherever books are sold
Seapoint Farms Unveils a New Healthy Superhero Snack with the Debut of Mighty Lil’ Lentils
Fueled by Plant Based Protein, New Artisan Snacks Are Deliciously Nutritious & Amazingly Versatile
HUNTINGTON BEACH, CA., JULY 27, 2020 - Ready to have your taste buds wowed?
We’re so excited to share Seapoint Farms’ (seapointfarms.com) latest innovation! Mighty Lil’ Lentils…a bold new plant powered artisan crafted snack that comes in four delicious flavors.
The launch of Mighty Lil’ Lentils marks the latest product innovation from Seapoint Farms. The new launch follows the introduction of the company’s popular Organic Edamame Pasta and Riced Veggie lines.
Who you Calling Lil’?
Sometimes bigger isn’t better. Behold – the Mighty Lil’ Lentil, everyone’s Superhero snack. Seapoint Farms has taken this nutritional powerhouse and created a variety of artisan-crafted lentils that are truly rich in flavor and loaded with wholesome goodness.
These crispy Lentils are fueled by plant-based protein, packed with nutrients, and bursting with flavor. Enjoy them on their own, pair them with your favorite beverage (wink wink), or add a crunch to your salads and trail mixes. How do you Lentil?
Crunchy, remarkably tasty, and distinct from just about every packaged snack on the market, Mighty Lil’ Lentils are ready to be enjoyed at home, at work or on the go. Vegetarian, gluten-free, and Non GMO project verified, Mighty Lil’ Lentils are also rich in nutrients, vitamins and fiber, free of trans fat and cholesterol and naturally sustainable. In addition, two flavors (Falafel and Pink Himalayan Salt) are vegan. Are you ready to hop on the lentil train?
Availability?
Mighty Lil’ Lentils can be purchased online at Amazon and iHerb. In-store retail availability will follow later this year.
A World of Flavor
Mighty Lil’ Lentils are available in four irresistible flavors:
Pink Himalayan Salt – Dusted with the perfect amount of salt (vegan and gluten-free)
Barbeque – Smokey, sweet, and savory (gluten-free)
Falafel – Exotic and mildly spicy (vegan and gluten-free)
Cinnamon Sugar – Slightly sweet and sassy (gluten-free)
Comments
Commenting on the new product launch, Philip Siegel, COO of Seapoint Farms, said, “While Mighty Lil’ Lentils are wholly consistent with Seapoint Farms’ commitment to exceptional nutritional quality and delicious flavor, these fun and versatile little snacks are unlike anything we’ve manufactured before. We wanted our first lentil-based item to be a perfect snack option not only for natural food devotees but also for the tens of millions of mainstream consumers out there who are ready to cut back on high-calorie, low-protein staples such as chips and pretzels. We’re heartened by the overwhelmingly positive response Mighty Lil’ Lentils have received from the public and from members of the natural food industry and are looking forward to their continued success for many years to come.”
About Seapoint Farms
Seapoint Farms is committed and passionate about creating a variety of great tasting healthy products. Based in Huntington Beach, California, Seapoint Farms is the largest importer and manufacturer of edamame products in America, offering a diverse array of premium-quality, great-tasting products and snacks. In addition to Mighty Lil’ Lentils, Seapoint Farms’ growing range of products includes Dry Roasted Edamame, a variety of Frozen Edamame, Riced Veggies, Riced Veggie Cuisine, Organic Edamame Pasta, and Seaweed Snacks. For more information follow Seapoint Farms on social media @seapointfarms and visit seapointfarms.com.
Honorary degree for Bradford clinician who set up one of world’s largest research projectsThis year’s graduates are ‘lanterns of hope’ says professor
11 August 2020 STRICTLY EMBARGOED UNTIL 00.01 ON WEDS AUG 12, 2020.A clinician who set up one of the world’s largest research studies has been awarded an honorary degree from the University of Bradford.Professor John Wright today receives an Honorary Degree of Doctor of Health for his long standing contribution to the field of healthcare and support for the University and wider Bradford community.Commenting on the award, he said: “I am both humbled and delighted. I have worked with the University of Bradford for almost 25 years and taken great joy in how it has grown and become such a symbol of civic pride in the city. I also plagiarised the University motto: ‘Making Knowledge Work’, when we set up the Bradford Institute for Health Research 15 years ago. ‘Making Research Real’ is our motto… That's' what all graduating students can look forward to: making a difference. Covid 19 has darkened the skies but [graduates] are lanterns of hope.”A clinician and epidemiologist with a background in hospital medicine and public health in the UK and in Africa, he has worked in virus hotspots around the world. He established and leads the Bradford Institute for Health Research and Wolfson Centre for Applied Health Research, working to speed up the translation of medical research into practice and policy. In 2007 he set up Born in Bradford, one of the largest research studies in the world, tracking the lives of over 30,000 children, to find out what influences their health and wellbeing, evidence from which is used to find the causes of common childhood illnesses and conditions and to explore the mental and social development of this generation.Prof Wright has also played a leading role in responding to the Covid-19 outbreak in Bradford, as one of the front-line staff at Bradford Royal Infirmary (BRI), as a reporter for the BBC raising awareness on how the BRI is coping with Covid-19 and as a key communicator informing communities how to stay safe during the pandemic. Professor Shirley Congdon, Vice Chancellor of the University of Bradford and newly appointed Chair of Yorkshire Universities, said: “Prof Wright has made major contributions in tackling the unacceptable inequalities in global health and more recently the fight against Covid-19. [He] is an inspiring individual who embodies the ‘Team Bradford’ spirit. We and our region are fortunate to have such a strong, determined and passionate research leader and it’s a privilege to award him the honorary Doctorate of Health.”Prof Wright is Visiting Professor in Clinical Epidemiology at the Universities of Bradford, York and Leeds and has authored three text books and over 300 papers and been awarded over £145 million in research award funding, £40 million as chief investigator. Additional informationIn 2016, he set up Born in Bradford’s Better Start cohort to test new approaches to providing the best support in the crucial period of early life. In 2019 he established ActEarly – developing a whole systems City Collaboratory approach to improving the health and life chances of children from deprived communities in London and Yorkshire.He is passionate about tackling the unacceptable inequalities in global health. In 1997 he set up a partnership with the Ministry of Health in Swaziland and has attracted charitable donations, Elton John AIDS Foundation and DFID grants to support applied research at the epicentre of the HIV/AIDS and TB epidemics in AfricaHe leads the Applied Health Research Unit in Swaziland and has provided 20 years of sustainable research with the UK. He has previously been Medical Advisor for Doctors of the World and in 2014 led their emergency response in Sierra Leone, setting up and running an Ebola Treatment Centre in extreme adversity. He was awarded the West Africa Medal by the Prime Minister. He is a great advocate for public engagement in science and research and has considerable experience in promoting research through mainstream and social media channels. He has extensive television experience (BBC, ITV, Sky) and has reported and presented for BBC Radio 4 for their long-running Born in Bradford series and for numerous programmes on international health. Most recently he recorded a series of programmes and podcasts for the BBC and World Service on ‘The NHS Frontline’ during the Covid-19 emergency.Pic cap: Professor John Wright, founder of Born in Bradford, one of the world’s largest research studies. A clinician and epidemiologist with a background in hospital medicine and public health in the UK and in Africa, he received an honorary degree of Doctor of Health in August 2020.
COVID-19 Shines A Bright Light On Disparities In Health Care Among People Of Color
New York, NY, August 11, 2020 ̶“During the coronavirus pandemic, people should guard their eyes with glasses or face shields to protect their eyes from virus infection,"said Dr. Daniel Laroche, Director of Glaucoma Services and President of Advanced Eyecare of New York. People also need to know, even though there are many concerns about COVID-19, common-sense precautions can significantly reduce the risk of infection, he says, adding: “Wash hands frequently, follow good contact lens hygiene and avoid rubbing or touching our mouth, nose, and especially our eyes.'' Dr. Laroche is also affiliated with the New York Eye and Ear Infirmary of Mount Sinai, Island Eye Surgical Center, and New York University.
The COVID-19 pandemic has also changed the way people visit their doctors. For patients over 60, Dr. Laroche advises it's better to stay home and do telehealth over the phone or video consultation until the pandemic flattens. He also encourages people to wear face masks on visits and maintain social distancing, even if they are in a health clinic. “Eyesight or human vision is one of the most important senses. As much as 80% of what we feel comes through our sense of sight. By protecting the eyes, people will reduce the chance of blindness and vision loss while also staying on top of any developing eye diseases, such as glaucoma and cataracts. A healthy brain function requires a healthy vision. The brain is our most essential organ, and It allows us to control other organs. Normal and healthy vision contributes to improved learning and comprehension for a better quality of life,” says Dr. Laroche.
Dr. Laroche says there is another critical issue that COVID-19 has brought to the forefront and that is the issue of health care disparities among Black and Brown people. “Nationally, African American deaths from COVID-19 are nearly two times greater than would be expected based on their share of the population. In four states, the rate is three or more times greater. In forty-two states, plus Washington, D.C., Hispanics make up a greater share of confirmed cases than their share of the population. In eight states it’s more than four times greater,” he says, adding: “In stark contrast, White deaths from COVID-19 are lower than their share of the population in thirty-seven states.”
Dr. Laroche says there are several things that can be done to not only address but to help combat this issue:
1. Increase the number of Black and Afro-Latino physicians worldwide.
2. Implement universal healthcare.
3. Increase wealth and education which produces better health.
4. Provide a living income stipend for poor people to access food and reduce malnutrition.
5. Eliminate racism to reduce stress.
6. Identify white supremist organizations as terrorist groups.
7. Recommend all corporations have people of color in the top management and leadership positions.
8. Eliminate sole reliance on standardized testing as the criteria to be used at entry to magnet schools.
9. Provide more funding to reduce homelessness and for mental health.
10.The government should also require medical school, research and hospital funding to diversify and benefit people of color.
About Dr. Daniel Laroche:
Dr. Laroche is an exceptional glaucoma specialist in New York. He studied and received his bachelor's degree from New York University and a medical doctorate with honors in research from Weil Cornell University Medical College. He underwent a medical internship at Montefiore Hospital and finished his Ophthalmology residency at Howard University Hospital in Washington D.C., where he was the chief resident in his third year. He later completed his glaucoma fellowship at New York Eye and Ear.
Health Canada Approves OPDIVO® (nivolumab) plus YERVOY® (ipilimumab) Combined with Limited Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
CheckMate -9LA trial results demonstrated superior overall survival versus chemotherapy, regardless of PD-L1 expression or tumor histology1
MONTREAL, Aug. 11, 2020 /CNW/ - Today, Bristol Myers Squibb Canada (BMS) announces Health Canada's approval of OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab) with two cycles of platinum-double chemotherapy for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), with no Epidermal Growth Factor Receptor (EGFR) or Anaplastic Lymphoma Kinase (ALK) tumour aberrations and no prior systemic therapy for metastatic NSCLC.1 Unlike traditional cancer therapies that target the tumour directly, immuno-oncology activates the body's own immune system to help recognize and attack cancer cells.2 This approval marks the availability of the first dual immuno-oncology plus limited course chemotherapy NSCLC treatment in Canada.
"Despite NSCLC being the most common form of lung cancer, every patient's lung cancer and treatment journey is unique," says Dr. Rosalyn Juergens, Associate Professor at McMaster University in the Department of Oncology, Division of Medical Oncology. "This approval provides a novel dual immuno-oncology-based option that may provide longer survival for patients within the Canadian treatment landscape."
The Health Canada approval was based on results from the randomised phase III clinical trial CheckMate -9LA. The study met both its primary and key secondary endpoints, demonstrating superior overall survival (OS), progression-free survival (PFS) and overall response rate (ORR) for the dual immunotherapy plus limited chemotherapy combination versus chemotherapy alone.
Study results showed a statistically significant improvement in OS for metastatic NSCLC patients treated with OPDIVO®, YERVOY® and chemotherapy compared to chemotherapy alone at a prespecified interim analysis (at a minimum follow-up of 8.1 months, [HR 0.69; 96.71% CI: 0.55, 0.87; p=0.0006]).3 With longer follow-up (minimum of 12.7 months), the dual immunotherapy with two cycles of chemotherapy continued to show sustained overall survival (OS) improvements over chemotherapy alone (median OS of 15.6 months versus 10.9 months, respectively [HR: 0.66, 95% CI: 0.55 to 0.80]). 3
"Over four years ago, OPDIVO® became the first immunotherapy approved for use in previously treated patients, defining a new era and changing the way NSCLC is treated. We are so proud to build on this legacy as OPDIVO® plus YERVOY® is approved as the first dual immunotherapy in a first-line NSCLC setting," said Al Reba, General Manager, BMS Canada. "We are committed to pursuing innovative approaches to lung cancer treatment so we can continue to deliver the right medicines for patients, increase their quality of life, and improve their chances of survival."
"Receiving a diagnosis of advanced lung cancer is devastating," says Shem Singh, Executive Director, Lung Cancer Canada. "We welcome this new Health Canada approval for a novel treatment regimen for patients where there is still significant unmet need."
CheckMate -9LA Study DesignCheckMate -9LA (NCT03215706) is Phase III, randomized open-label, multi-centre study evaluating OPDIVO® plus YERVOY® combined with two cycles of platinum-doublet chemotherapy versus chemotherapy (four cycles followed by optional pemetrexed maintenance therapy if eligible) as a first-line treatment in patients with metastatic or recurrent NSCLC regardless of PD-L1 expression and histology.
Health Canada and Project Orbis Collaboration Aims to Provide Earlier Availability to Cancer Treatments4 Project Orbis is an initiative of the United States Food and Drug Administration (FDA) Oncology Center of Excellence. This submission was part of the FDA's Project Orbis initiative, enabling concurrent review by the FDA and the health authorities in Australia, Canada and Singapore.
Pivotal clinical trials in oncology are commonly conducted internationally and these global trials are increasingly important for investigating the safety and effectiveness of cancer drugs for approval across jurisdictions. Future drug development may benefit by establishing a greater uniformity of new global standards of treatment, leading to the optimal design of these important trials.
About Bristol Myers Squibb Canada Co. Bristol Myers Squibb Canada Co. is an indirect wholly-owned subsidiary of Bristol Myers Squibb Company, a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb Canada Co. employs more than 400 people across the country. For more information, please visit https://www.bms.com/ca/en.
About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.
Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol Myers Squibb company and Juno Therapeutics, a Bristol Myers Squibb company.
3 Reck M, Tudor-Eilade C, Cobo Dols M, et al. Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles of chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA [abstract]. In: American Society of Clinical Oncology (ASCO) Annual Meeting; May 29 – June 2, 2020; Virtual.
A Plus Creative Inc.: Helping Kids Feel the Love, Stay Connected
Using Technology to Face the Challenges of COVID-19
TORONTO, Aug. 11, 2020 /CNW/ - A Plus Creative, a Toronto digital ad agency, is spearheading a fundraising campaign in support of SickKids Foundation called Feel the Love, Stay Connected. The goal is to help kids stay digitally connected to their loved ones from the hospital, when they can't be face to face.
Today's new world and social isolation is tough, especially for children who find themselves in the hospital. Kids thrive on human connection and the feeling of love. Anastasia Adani, President and Chief Creative of A Plus Creative, worked with physicians at The Hospital for Sick Children (SickKids) and her own team to come up with a creative solution. "We want children to stay connected to their families," says Adani. "Our goal is to raise funds to purchase computer tablets for SickKids. We are excited and encourage everyone to join us!"
SickKids is a world-class paediatric teaching hospital dedicated to improving children's health. It is affiliated with the University of Toronto and remains Canada's leader in paediatric care. SickKids performs about 13,000 operations every year.
The Feel the Love, Stay Connected campaign has the potential to help many children during the current COVID-19 crisis and well beyond it. Lisa Walker, Manager Cause Marketing for SickKids Foundation, recognizes its value. "We rely on generous support from the community and are grateful to A Plus Creative for their commitment to our causes. The funds raised from this initiative will help SickKids provide technology to help keep patients and families connected and engaged during this challenging time," says Walker.
The campaign is about one-quarter of the way to meeting its goal of $30,000, and A Plus invites all Canadians to participate. 100% of donations go to SickKids Foundation. Donations are requested at https://www.sickkidsfoundation.com/page/apluscreative.
When it comes to stepping up for local communities in need, A Plus continues to find ways to be a difference maker.
About A Plus Creative: A Plus Creative is a leading digital advertising agency in Toronto. They create high volume, rich-media omni-channel content that connects with customers on an emotional level and drives business results. They are creative partners with many of Canada's best companies. Since COVID-19's arrival, the A Plus team has been actively seeking out local community initiatives to support, such as CAMH, Feed Ontario and The Angel Project. For more information, contact info@apluscreative.ca or visit https://www.apluscreative.ca/.
SOURCE A Plus Creative Inc.
AMD Global Telemedicine and ITelemed announce new business partnership
LONDON, ON, Aug. 11, 2020 /CNW/ - iTelemed a London, Ontario based provider of Virtual Healthcare solutions is proud to announce its partnership with AMD Global Telemedicine, a Chelmsford, Massachusetts based provider of Digital and telehealth technology solutions worldwide.
This partnership arrives at a time when Canada is most in need of support for its marginalized populations within Congregate living facilities during the Covid19 pandemic. This partnership is being backed by the creation of a full training program and accreditation support through Fanshawe College Corporate Training Solutions (CTS) which will bring the needed infrastructure support to Canada's evolving Digital Health Ecosystem. AMD Global Telemedicine brings world class support and business experience to this relationship and is committed to supporting and developing growth and solutions with Canadian-based innovation and Canadian-based economic development within the Ecosystem being supported by this deal.
ITelemed has been innovating within the public-funded Healthcare space and believes virtual healthcare should be accessible to all Canadians, most importantly to medically fragile and marginalized individuals. AMD Global Telemedicine is a strong partner with robust infrastructure supports and has a similar passion and proven record for reaching marginalized and remote populations. AMD's proven solutions with software platform "AGNES", integration with peripherals and interoperability within EHRs will provide incredible telemedicine technology support to Canada's newly developing Digital Health Ecosystem. ITelemed in partnership with Fanshawe CTS will bring robust training and support required for the iTelemed Mobile Virtual Medical Kits that will be accredited and quickly replicated across Canada to support the fight on Covid19.
We are excited to announce this partnership for two reasons:
1. Covid19 has been particularly hard upon individuals within congregate living facilities and the iTelemed MVM kits are an immediate solution to bring virtual "care in place" to these settings. This solution is now being backed by AMD Global Telemedicine resource supports and ability to scale across Canada for the fight on Covid19.
2. This partnership brings together Canadian iTelemed Innovation, Canadian based Fanshawe College training and development supported by US based AMD Global Telemedicine technology and infrastructure support. This partnership is not just a win-win for the partners involved, but a win-win for Canada in growing local and national economies around Digital Healthcare provision of service, infrastructure support and job metrics, research and training for new models of healthcare, innovation and technologic design between Canada and international corporations such as AMD.
ABOUT iTelemed: ITelemed/ CTG is a full solution Software, Hardware, Tech Support and training providers, connecting Patients with Physicians, Care givers & Providers remotely. We fully enable Doctors to remotely care for patients, whether from our physical locations or home offices.
CTG is OTN registered provider of Telemedicine services in Ontario.
Our Corporate vision:
-Patient Centered Healthcare
-Innovative Healthcare Accessibility
-Providers efficiency and Experience
About AMD Global Telemedicine:
AMD Global Telemedicine has been a pioneer of Telemedicine and an industry leader in telehealth solutions for the last 30 years. As AMD's mission has grown over the years to positively impact healthcare delivery using the latest advancements in digital technology, their range of products and solutions have evolved. AMD's telehealth solutions include software platforms, integrated medical devices, and telemedicine bundled kits that empower healthcare providers to deliver the highest possible level of care to any patient, anywhere, regardless of the circumstances.
About Fanshawe CTS
Fanshawe CTS provides training and business solutions across a wide variety of industries including Business, Transportation, Healthcare, and Trades and Technology. Workshops and course are available online, in class, or in a blended format and are customized to meet your specific needs and goals. Servicing London and Southwestern Ontario visit FanshaweC.ca/CTS to learn more.
New daily disposable lens launches as solution for new contact lens wearers
TORONTO, Aug. 11, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to launch the latest innovation to its robust contact lens portfolio in Canada, PRECISION1® daily disposable, silicone hydrogel (SiHy) contact lenses.
Designed to address the common issues that cause 1-in-5 new wearers to discontinue contact lens within the first year (poor vision, comfort and handling issues1), Precision1® helps lens wearers overcome these issues providing precise vision, dependable comfort and ease of use.1, 2
"We're thrilled to introduce PRECISION1® into the Canadian market," says Brian O'Neal, General Manager for Alcon Canada. "PRECISION1® demonstrates our commitment to helping people see brilliantly, especially those new to daily disposable lenses who have busy, active lifestyles that need exceptional long-lasting performance. It complements our premium DAILIES TOTAL1® and value-driven DAILIES® AquaComfort® PLUS, contact lenses further expanding our contact lens portfolio."
PRECISION1® is the first daily disposable contact lens to use SMARTSURFACE™ Technology, a permanent, micro-thin, high performance layer of moisture at the lens surface that helps support a stable tear film to deliver lasting visual performance and from morning to night. 3
New Clinical data also shows five times more contact lens wearers "strongly preferred" PRECISION1® vs. 1-Day ACUVUE Moist.The head-to-head study demonstrated superiority of PRECISION1® over top-selling 1-Day ACUVUE Moist contact lenses in attributes critical for successful contact lens wear including vision, comfort, and handling.2,3
"With the launch of PRECISION1®, we now have a daily disposable contact lens option that addresses the needs of a broad group of patients and delivers an outstanding wearing experience," says Dr. Judy Parks, Hamilton-based optometrist. "I'm confident that offering my patients PRECISION1® gives them a lens they can start and stay in."
PRECISION1® comes to the Canadian market after launching in 2019 in Australia, New Zealand and the United States, with more launches expected around the globe in 2020 and 2021.
Distribution of PRECISION1® to optometrists has started and will become widely available across Canada in the fall of 2020. For more information, visit PRECISION1.ca.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca. You can also connect with us on Instagram and Facebook.
_____________________________
1 Sulley A, Young G, Hunt C. Retention rates in new contact lens wearers. Eye and Contact Lens. 2018;44:S273-S282
2 Cummings S, Giedd B, Pearson C. Clinical performance of a new daily disposable spherical contact lens
3 Alcon data on file, 2018. Based on mean subjective ratings from a prospective, randomized, bilateral crossover, double-masked, controlled clinical trial of PRECISION1 and 1-Day ACUVUE MOIST contact lenses; Trademarks are the property of their respective owners
SOURCE Alcon Canada
Province Brands of Canada Names Jennifer Dianne Thomas as Chief Executive Officer
Company charts bold path with groundbreaking technology
Ms. Thomas replaces Dooma Wendschuh, Co-Founder and CEO since the company was formed in 2016. Mr. Wendschuh informed the Board in December, 2019, of his intent to transition from executive leadership, and planning has been underway since. Mr. Wendschuh remains a full-time employee of Province Brands dedicated to the company’s success as a co-founder.
“Dooma has taken Province Brands from an idea that met with widespread early resistance to the verge of market-ready launch with facilities under construction, valuable IP, a broad vision, emerging product offerings, and he will remain an important part of Province Brands’ future,” said Ms. Thomas. “I’m excited about the road ahead and thank Dooma and the Board for its confidence and full support.”
Ms. Thomas added: “I’m excited to take over as CEO of Province Brands to create and deliver new solutions and revenue streams that allow the business to grow in these challenging times. In addition to innovative thinking, the current environment in the industry and world at large presents a confluence of constrains that require risk mitigation and sound legal, financial and compliance experience that I have accumulated over my 12 years of practicing at Schulte Roth & Zabel LLP, Jones Day, and with other cannabis companies. These experiences have prepared me to lead Province Brands’ to a bright future.
Since co-founding Province Brands four years ago, Ms. Thomas has spearheaded multiple vital strategic initiatives and partnerships, played a major role in managing the business, overseen all aspects of the company’s legal and licensure strategies, and managed the company’s legal and finance department.
“Under Jennifer’s leadership, Province Brands is poised to transform the brewing industry,” said Mr. Wendschuh. “There is no one better suited for the job, more highly regarded by the team, or more capable to lead this company. I’ve been honored to have Jennifer as a partner for the past four years and I’ve been thrilled to watch her succeed at every task she’s undertaken. Her bold vision for the company is exciting and I’m thrilled to help her succeed.”
Ms. Thomas for two years has represented Province Brands on the board of the Cannabis Beverage Producers Alliance. She founded the State Bar of Georgia’s Cannabis and Hemp Bar Section. Prior to Co-Founding Province Brands, Ms. Thomas held roles including Corporate Associate at Schulte Roth & Zabel LLP, and Corporate Associate at Jones Day. She earned her Juris Doctor degree from Howard University School of Law and holds a Bachelor of Fine Arts degree from Southern Methodist University.
Today’s news follows the April 16, 2020, announcement that Province Brands closed a CAD$2.2 million round of new funding.
About Province Brands of Canada
Province Brands of Canada is a beverage technology & branded products company. Province Brands of Canada has created a patent-pending technology that we believe creates a better class of beer. For the first time ever, beverages can be brewed from non-starch plant material and most types of food waste (for example “spent grains” left over after brewing the old way). Our brewing technology results in beer that is low calorie, low in carbohydrates and best of all gluten free. Brewers using our technology can experiment with new flavors, make beers from locally sourced materials, and even make a second batch of beer from their spent grains - all the while, reducing their carbon emissions and waste disposal costs. Cannabis beverage companies can use the technology to make authentic non-alcoholic fermented beverages brewed directly from the industry's primary waste stream (stalks, stems & roots).
Province Brands of Canada’s founding legacy is based in brewing but as a beverage technology company we are also developing a propriety extract that makes clean, sustainable, and tasty sugars/syrups from non-starch biomass (including plant refuse). We are excited to serve the beverage industry and beverage consumers with cannabis and hemp derived sugar.
We anticipate that functional beverage companies will make great tasting gluten-free beverages that are sweetened with our sugar technology or fermented beverages with our brewing technology.
This is a proven technology that is going to change the beverage industry forever.
‘Shatter the Stereotypes Empowerment Summit’ Set to Reignite Optimism Among Black Men
Stafford, TX, August 11, 2020 – Following the intense racial tensions of the past few months, Texas Life Coach Michael Taylor is gearing up to host a ‘Shatter the Stereotypes Empowerment Summit’ to reignite optimism in African-American men.
The online summit is a seven-part series scheduled to kick off on August 14th at 7pm CST. There is no charge for the event that features a line-up of impressive and notable speakers, such as Beyonce’s father Mathew Knowles, Dr. Tommy Curry, Dr. Steve Perry, Jon T. Walton, Bradley Rapier, and Dr. Jerome Teelucksinghwho will deliver presentations on topics such as:
1. How to tap into the DNA of achievers for support in building an extraordinary life
2. How to navigate feelings of ‘Onlyness’ as the only person of color in professional and social settings
3. How International Men’s Day can help eradicate social issues like suicide, father-lessness, domestic violence, and addictions
4. Why Education is the key to success for black men
5. Why it is important to have black male educators … and so much more.
The gruesome killing of George Floyd could cause many black men to shrink back and feel hopeless. But now more than ever, there is a call for them to remain optimistic as the current momentum created by the recent uprising can create lasting changes for not just them, but the entire black community. Taylor is riding this momentum with this summit and wants to empower black men during this critical time in black history.
“Despite the current racial tensions in America I am extremely optimistic about the future for black men. It is my fervent belief that black men need hope, motivation and education, and that is the intention of this summit. The key to our success lies in our willingness to change our inner narrative about ourselves and to not accept negative stereotypes; therefore, Shatter the Stereotypes is the movement I've created to empower black men to live extraordinary lives," says Taylor.
Shatter the Stereotypes Empowerment Summit is based on one of Taylor’s best-selling books, Shattering Black Male Stereotypes. The book offers an insightful look into the ten most destructive illusions about black men and delivers proven solutions and techniques they can use to overcome the stereotype mindset and live above thegeneric negative illusions about the black race. But it’s not just about a book. It’s an entire movement dedicated to empowering black men through online courses, webinars, seminars, podcasts and apparel.
